These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 7197780)
21. Dehydro-dermorphins. I. Influence of the stereo-orientation of aromatic groups in dermorphin-(1-5)-peptides to opioid activity. Salvadori S; Marastoni M; Balboni G; Marzola G; Tomatis R Int J Pept Protein Res; 1986 Sep; 28(3):254-61. PubMed ID: 3781739 [TBL] [Abstract][Full Text] [Related]
23. 2',6'-dimethylphenylalanine (Dmp) can mimic the N-terminal Tyr in opioid peptides. Sasaki Y; Sasaki A; Ariizumi T; Igari Y; Sato K; Kohara H; Niizuma H; Ambo A Biol Pharm Bull; 2004 Feb; 27(2):244-7. PubMed ID: 14758045 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6. Biondi L; Giannini E; Filira F; Gobbo M; Marastoni M; Negri L; Scolaro B; Tomatisc R; Rocchi R J Pept Sci; 2003 Oct; 9(10):638-48. PubMed ID: 14620129 [TBL] [Abstract][Full Text] [Related]
25. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor. Amiche M; Sagan S; Mor A; Delfour A; Nicolas P Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911 [TBL] [Abstract][Full Text] [Related]
26. Opioid peptides. VIII. Synthesis and preliminary biological activity of [D-Phe3]- or [alpha,beta-dehydro-Phe3]dermorphin tetrapeptides. Salvadori S; Marastoni M; Balboni G; Tomatis R Farmaco Sci; 1985 Jun; 40(6):454-8. PubMed ID: 4029390 [TBL] [Abstract][Full Text] [Related]
27. Design of opioid peptides for a potential delta-receptor affinity label function: comparison with the mu-specific Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone. Rónai AZ; Hepp J; Magyar A; Borsodi A; Medzihradszky K Pharmacology; 1994 Aug; 49(2):121-31. PubMed ID: 7972321 [TBL] [Abstract][Full Text] [Related]
28. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor. Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761 [TBL] [Abstract][Full Text] [Related]
29. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides. Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134 [TBL] [Abstract][Full Text] [Related]
30. Structure-activity studies of dermorphin. The role of side chains of amino acid residues on the biological activity of dermorphin. Darłak K; Grzonka Z; Krzaścik P; Janicki P; Gumułka SW Peptides; 1984; 5(4):687-9. PubMed ID: 6494023 [TBL] [Abstract][Full Text] [Related]
31. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation. Keller M; Boissard C; Patiny L; Chung NN; Lemieux C; Mutter M; Schiller PW J Med Chem; 2001 Nov; 44(23):3896-903. PubMed ID: 11689075 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of dermorphins, a new class of opiate-like peptides. de Castiglione R; Faoro F; Perseo G; Piani S Int J Pept Protein Res; 1981 Feb; 17(2):263-72. PubMed ID: 7228501 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers. Schiller PW; Nguyen TM; Lemieux C; Maziak LA J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological studies of a series of dermorphin related tetrapeptides. Sarto GP; Borea PA; Salvadori S; Tomatis R Arzneimittelforschung; 1983; 33(11):1577-9. PubMed ID: 6686453 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and opioid activity of partial retro-inverso analogs of dermorphin. Salvadori S; Marastoni M; Balboni G; Sarto G; Tomatis R Int J Pept Protein Res; 1985 May; 25(5):526-33. PubMed ID: 4019032 [TBL] [Abstract][Full Text] [Related]
36. Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids. Yaksh TL; Malmberg AB; Ro S; Schiller P; Goodman M J Pharmacol Exp Ther; 1995 Oct; 275(1):63-72. PubMed ID: 7562596 [TBL] [Abstract][Full Text] [Related]
37. Opioid peptides. Pharmacological activity and lipophilic character of dermorphin oligopeptides. IV. Borea PA; Sarto GP; Salvadori S; Tomatis R Farmaco Sci; 1983 Jul; 38(7):521-6. PubMed ID: 6617850 [TBL] [Abstract][Full Text] [Related]
38. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors. Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681 [TBL] [Abstract][Full Text] [Related]
39. Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat. Negri L; Erspamer GF; Severini C; Potenza RL; Melchiorri P; Erspamer V Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7203-7. PubMed ID: 1353890 [TBL] [Abstract][Full Text] [Related]
40. [Comparison of the opioid activity of a number of enkephalin and dermorphin analogs]. Chichenkov ON; Sumbatian NV; Riabtseva ON; Korshunova GA; Shorr VA Farmakol Toksikol; 1988; 51(5):17-20. PubMed ID: 2850219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]